1. Recombinant factor VIIa: review of efficacy, dosing regimens, and safety in patients with congenital or acquired factor VIII or IX inhibitors;Abshire;Journal of Thrombosis and Haemostasis,2004
2. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias;Acharya;Journal of Thrombosis and Haemostasis,2004
3. Is the incidence and prevalence of inhibitors greater with recombinant products? Yes;Aledort;Journal of Thrombosis and Haemostasis,2004
4. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals;Algiman;Proceedings of the National Academy of Sciences of the United States of America,1992
5. Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives;Ananyeva;Blood Coagulation and Fibrinolysis,2004